Wealthcare Advisory Partners LLC lifted its position in IBM (NYSE:IBM) by 10.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,185 shares of the technology company’s stock after acquiring an additional 208 shares during the period. Wealthcare Advisory Partners LLC’s holdings in IBM were worth $301,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in the company. BB&T Corp grew its position in IBM by 1.8% during the first quarter. BB&T Corp now owns 51,779 shares of the technology company’s stock valued at $7,306,000 after purchasing an additional 901 shares in the last quarter. Adell Harriman & Carpenter Inc. purchased a new position in IBM during the first quarter valued at approximately $207,000. Greenleaf Trust grew its position in IBM by 12.4% during the first quarter. Greenleaf Trust now owns 8,057 shares of the technology company’s stock valued at $1,137,000 after purchasing an additional 891 shares in the last quarter. Wesbanco Bank Inc. grew its position in IBM by 2.2% during the first quarter. Wesbanco Bank Inc. now owns 115,867 shares of the technology company’s stock valued at $16,349,000 after purchasing an additional 2,522 shares in the last quarter. Finally, Swedbank grew its position in IBM by 21.1% during the first quarter. Swedbank now owns 1,404,199 shares of the technology company’s stock valued at $198,132,000 after purchasing an additional 244,949 shares in the last quarter. 55.22% of the stock is currently owned by institutional investors and hedge funds.
IBM stock traded down $3.97 during trading hours on Friday, hitting $136.13. The company’s stock had a trading volume of 5,111,833 shares, compared to its average volume of 4,730,077. The company has a debt-to-equity ratio of 3.51, a current ratio of 1.83 and a quick ratio of 1.79. The stock has a market cap of $123.23 billion, a P/E ratio of 9.86, a PEG ratio of 2.06 and a beta of 1.28. IBM has a 12 month low of $105.94 and a 12 month high of $154.36. The stock has a 50 day moving average of $143.68.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 10th. Stockholders of record on Friday, August 9th will be paid a $1.62 dividend. This represents a $6.48 dividend on an annualized basis and a dividend yield of 4.76%. The ex-dividend date of this dividend is Thursday, August 8th. IBM’s payout ratio is 46.92%.
In other news, SVP Kenneth M. Keverian sold 2,690 shares of the business’s stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $135.50, for a total value of $364,495.00. Following the completion of the sale, the senior vice president now directly owns 34,665 shares in the company, valued at $4,697,107.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Kenneth M. Keverian sold 2,083 shares of the business’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $132.00, for a total transaction of $274,956.00. Following the completion of the sale, the senior vice president now owns 34,465 shares of the company’s stock, valued at $4,549,380. The disclosure for this sale can be found here. Insiders sold 7,000 shares of company stock valued at $940,430 over the last 90 days. 0.19% of the stock is owned by corporate insiders.
A number of research analysts recently commented on the stock. BMO Capital Markets boosted their price objective on shares of IBM from $147.00 to $155.00 and gave the company a “market perform” rating in a research report on Wednesday, April 17th. They noted that the move was a valuation call. Morgan Stanley initiated coverage on shares of IBM in a research report on Thursday, August 1st. They set an “overweight” rating and a $170.00 price objective on the stock. Zacks Investment Research raised shares of IBM from a “sell” rating to a “hold” rating in a research report on Monday, April 22nd. ValuEngine raised shares of IBM from a “sell” rating to a “hold” rating in a research report on Wednesday, May 1st. Finally, UBS Group set a $160.00 target price on shares of IBM and gave the stock a “buy” rating in a research report on Wednesday, April 17th. One investment analyst has rated the stock with a sell rating, twelve have given a hold rating and eight have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $155.00.
International Business Machines Corporation operates as an integrated technology and services company worldwide. Its Cognitive Solutions segment offers a portfolio of enterprise artificial intelligence platforms, such as analytics and data management platforms, cloud data services, talent management, and industry solutions primarily under the Watson Platform, Watson Health, and Watson Internet of Things names.
Featured Story: What are the Benefits of Index Funds?
Want to see what other hedge funds are holding IBM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IBM (NYSE:IBM).
Receive News & Ratings for IBM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBM and related companies with MarketBeat.com's FREE daily email newsletter.